| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/27/2003 | WO2003015612A2 Materials and methods to promote repair of nerve tissue |
| 02/27/2003 | WO2003015606A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 02/27/2003 | WO2003002123A3 Therapeutic combinations for the treatment of hormone deficiencies |
| 02/27/2003 | WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 02/27/2003 | WO2002098413A3 Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof |
| 02/27/2003 | WO2002091992A3 Targeted delivery of drugs for the treatment of parasitic infections |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002074794A3 Compositions useful in gene therapy |
| 02/27/2003 | WO2002072018A3 A cream-t0-powder dermatological composition |
| 02/27/2003 | WO2002067850A3 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 02/27/2003 | WO2002062304A3 Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate |
| 02/27/2003 | WO2002061040A3 Gene delivery formulations and methods for treatment of ischemic conditions |
| 02/27/2003 | WO2002057422A3 Ternary biomolecule/polymer/surface-based immobilization systems |
| 02/27/2003 | WO2002056908A3 Artificial antigen-presenting cells |
| 02/27/2003 | WO2002056840A3 Cosmetic and/or pharmaceutical agent containing acylated amino acid |
| 02/27/2003 | WO2002055011A3 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002044267A3 Cosmetic, pharmaceutical and dermatological products containing an electrolyte |
| 02/27/2003 | WO2002043695A3 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol |
| 02/27/2003 | WO2002041844A3 Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
| 02/27/2003 | WO2002039993A3 Pharmaceutival preparations comprising corticosteroids and antiinfective agents |
| 02/27/2003 | WO2002038105A3 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 02/27/2003 | WO2002030469A3 Beta-lactam antibiotic-polysaccharide complex |
| 02/27/2003 | WO2002020000A3 Combined estrogen blockade of the breast with exemestane and raloxifene |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | US20030040537 Treatment of migraine headache |
| 02/27/2003 | US20030040524 Pyrimidine compounds and methods for making and using the same |
| 02/27/2003 | US20030040497 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/27/2003 | US20030040496 Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehicles |
| 02/27/2003 | US20030040492 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 02/27/2003 | US20030040487 Polymer complexes of glucuronoglucanes |
| 02/27/2003 | US20030040127 Multiple epitopes connected by a carrier |
| 02/27/2003 | US20030040112 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
| 02/27/2003 | US20030039960 Transferring therapeutic agent into body cavity of mammal; prepare therapeutic agent, obtain mammal, inject mammal, monitor mamamlian response to therapeutic agent |
| 02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
| 02/27/2003 | US20030039956 Compositions and methods for increasing the oral absorption of antimicrobials |
| 02/27/2003 | US20030039720 Containing agar |
| 02/27/2003 | US20030039698 Sustained-release preparation |
| 02/27/2003 | US20030039692 Sustained release oral formulations |
| 02/27/2003 | US20030039691 Compression coatings |
| 02/27/2003 | US20030039689 Prodrug in polymer matrix; insertion into body |
| 02/27/2003 | US20030039687 Using Carbomer |
| 02/27/2003 | US20030039686 Increased absorption; aqueous solution containing fatty acid, or salt thereof |
| 02/27/2003 | US20030039684 Preparation of a directly mouldable tabletting auxiliary |
| 02/27/2003 | US20030039683 Multilayer binding; lamellar surface structure |
| 02/27/2003 | US20030039675 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/27/2003 | US20030039669 Use of a composition containing an effective quantity of at least one chelating agent for partially or totally reducing the symptoms associated with histamine release in the organism |
| 02/27/2003 | US20030039656 Modified reoviral therapy |
| 02/27/2003 | US20030039655 Novel engineered superantigen for human therapy |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039614 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 02/27/2003 | US20030039613 Novel therapeutic delivery systems |
| 02/27/2003 | US20030038183 Spray gun for enteric coating and process for producing enteric coating preparation |
| 02/27/2003 | US20030037673 Method and system for treating air with an iodinated resin |
| 02/27/2003 | CA2493349A1 Delayed and sustained drug release |
| 02/27/2003 | CA2460352A1 Composition and transdermal drug delivery device |
| 02/27/2003 | CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | CA2457328A1 Agents for enhancing the immune response |
| 02/27/2003 | CA2457086A1 Oral care substance delivery strip |
| 02/27/2003 | CA2456988A1 Gas microsphere liposome composites |
| 02/27/2003 | CA2456976A1 Expandable gastric retention device |
| 02/27/2003 | CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | CA2456725A1 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 02/27/2003 | CA2456477A1 Antimicrobial cationic peptides and formulations thereof |
| 02/27/2003 | CA2456149A1 Recombinant conjugate polypeptides for photodynamic therapy |
| 02/27/2003 | CA2455827A1 Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan |
| 02/27/2003 | CA2454913A1 Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2h-pryrazol-3-yl)-3-¬4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl|-urea and a cyclodextrin |
| 02/27/2003 | CA2454853A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2454671A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/26/2003 | WO2003009870A1 Remedies for mammary cancer |
| 02/26/2003 | EP1285947A1 Antimicrobial composition |
| 02/26/2003 | EP1285942A1 Polypeptide derivatives and nucleic acid carriers containing the same |
| 02/26/2003 | EP1285667A2 Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances |
| 02/26/2003 | EP1285665A1 Liquid gonadotropin containing formulations |
| 02/26/2003 | EP1285660A1 Zinc-supplementary compositions for oral administration |
| 02/26/2003 | EP1285655A1 Stabilized pharmaceutical compositions containing calcium channel blockers |
| 02/26/2003 | EP1285021A1 Material based on biodegradable polymers and method for preparing same |
| 02/26/2003 | EP1284992A2 Polyubiquitin based hydrogel and uses thereof |
| 02/26/2003 | EP1284785A2 Medicament-loaded transdermal reservoir and method for its formation |
| 02/26/2003 | EP1284771A1 Aerosol container for formulations of salmeterol xinafoate |
| 02/26/2003 | EP1284754A1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 02/26/2003 | EP1284744A1 Antimigraine combination comprising sapindus and emblica extracts |
| 02/26/2003 | EP1284740A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds |
| 02/26/2003 | EP1284736A2 Opioid antagonist compositions and dosage forms |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 02/26/2003 | EP1284718A2 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 02/26/2003 | EP1284717A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 02/26/2003 | EP1284716A2 Self-emulsifying active substance formulation and use of this formulation |
| 02/26/2003 | EP1284601A2 Allantoin-containing skin cream |
| 02/26/2003 | EP1169019B1 Pharmaceutical aerosol formulation |
| 02/26/2003 | EP1153615B1 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 02/26/2003 | EP1028746B1 Method for producing igf-i sustained-release formulations |
| 02/26/2003 | EP0850059B1 Pharmaceutical formulations containing darifenacin |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | EP0732913B1 SYNTHETIC VISCOELASTIC MATERIAL for physiological applications such as FOR OPHTHALMIC APPLICATIONs |
| 02/26/2003 | CN1399655A Swelling and deswelling polymer blends |